Carcinoma, Ovarian Epithelial: all 1,619 studies
Page 12 of 17. Open to participants first (245), then studies with results posted, then the rest; newest registration first within each.
- Mifepristone and Eribulin in Patients With Metastatic Triple Negative Breast Cancer or Other Specified Solid TumorsCompletedNCT02014337Phase 1
- Propranolol Hydrochloride in Treating Patients With Locally Recurrent or Metastatic Solid Tumors That Cannot Be Removed By SurgeryCompletedNCT02013492Early Phase 1
- EC17 for Intraoperative Imaging in Occult Ovarian CancerCompletedNCT02000778Phase 1
- A Study of DNIB0600A in Comparison With Pegylated Liposomal Doxorubicin (PLD) in Participants With Platinum-Resistant Ovarian Cancer (PROC)TerminatedNCT01991210Phase 2
- Observation of Bevacizumab Plus Front-line Chemotherapy in Patients With Ovarian CancerCompletedNCT01982500
- Vaccine Therapy and IDO1 Inhibitor INCB024360 in Treating Patients With Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Who Are in RemissionWithdrawnNCT01982487Phase 1/2
- Study of Birinapant in Combination With Conatumumab in Subjects With Relapsed Ovarian CancerCompletedNCT01940172Phase 1
- Palliative Care in Improving Quality of Life and Symptoms in Patients With Stage III-IV Pancreatic or Ovarian CancerWithdrawnNCT01927393Not applicable
- PankoMab-GEX™ Versus Placebo as Maintenance Therapy in Advanced Ovarian CancerCompletedNCT01899599Phase 2
- Dual PETOvac - Dual Time PET/CT in the Preoperative Assessment of Ovarian CancerStatus unknownNCT01889615
- Salpingectomy vs Tubal Sterilisation in Low Risk for Ovarian Cancer Women and Its Effect on Ovarian ReserveStatus unknownNCT01888159Not applicable
- Imaging Tumor Hypoxia With 18F-EF5 PET in Recurrent or Metastatic Clear Cell Ovarian CancerTerminatedNCT01881451
- An Observational Study of YONDELIS®+PLD for the Treatment of Patients With Platinum-sensitive Relapse of Ovarian CancerCompletedNCT01869400
- An Observational Study of Avastin (Bevacizumab) in Combination With Chemotherapy as First-Line Treatment in Patients With Advanced Ovarian Cancer (OSCAR 1)CompletedNCT01863693
- A Study of Docetaxel and Lobaplatin Versus Docetaxel and Carboplatin Combination Regimen in Patients With Platinum-sensitive (>6 Months) Relapsed Ovarian CancerStatus unknownNCT01851746
- Prevention of Ovarian Cancer in Women Participating in MammographyCompletedNCT01851109Not applicable
- Neoadjuvant Therapy in Advanced Ovarian Cancer With AvastinTerminatedNCT01847677Phase 2
- Family Caregiver Palliative Care Intervention in Supporting Caregivers of Patients With Stage II-IV Gastrointestinal, Gynecologic, Urologic and Lung CancersCompletedNCT01846520Not applicable
- Clinical Study in Treatment of Malignant Ascites of Ovarian Cancer With Intraperitoneal Injection Bevacizumab Combined With Intraperitoneal Hyperthermic Perfusion ChemotherapyStatus unknownNCT01838538Phase 2
- Evaluation of Optimal Treatment With Bevacizumab in Patients With Platinum-sensitive Recurrent Ovarian CancerCompletedNCT01837251Phase 3
- Imaging of Peritoneal Carcinomatosis From Ovarian Carcinoma PatientsCompletedNCT01834469Phase 1/2
- First Line Ovarian Cancer Treatment - Cohort StudyCompletedNCT01832415
- 89Zr-MMOT PET Imaging in Pancreatic and Ovarian Cancer PatientsCompletedNCT01832116Phase 1
- A Pilot Test for Newly Developed Synoptic Operative Template for Ovarian Cancer (SOTOC): National Cancer Center - Peritoneal Carcinomatosis IndexStatus unknownNCT01823731
- Feasibility and Clinical Activity of Initial Intraperitoneal Catumaxomab Followed by Chemotherapy in Patients With Recurrent Ovarian CancerCompletedNCT01815528Phase 2
- A Pivotal Bioequivalence Study of DOXIL/CAELYX (Doxorubicin HCL) in Patients With Advanced or Refractory Solid Malignancies Including Patients With Ovarian CancerCompletedNCT01815294Phase 1
- STELLA Trial: Transperitoneal vs. Extraperitoneal Approach for Laparoscopic Staging of Endometrial/Ovarian CancerCompletedNCT01810874Not applicable
- Pelvic Floor Muscle Training in Treating Urinary Incontinence in Gynecologic Cancer SurvivorsCompletedNCT01806350Not applicable
- Bevacizumab Beyond Progression in Platinum Sensitive Ovarian CancerStatus unknownNCT01802749Phase 3
- BOVARI: A Non-Interventional Study of Avastin (Bevacizumab) as Front-Line Treatment in Patients With Ovarian CancerCompletedNCT01788995
- A Novel Method of Screening for Ovarian Cancer Using Gynecologic Fluids and MucusCompletedNCT01787656
- Phase I/Ib Study of Paclitaxel in Combination With VS-6063 in Patients With Advanced Ovarian CancerCompletedNCT01778803Phase 1
- Study With Trabectedin in BRCA1 and BRCA2 Mutation Carrier and BRCAness Phenotype Ovarian CancerStatus unknownNCT01772979Phase 2
- Oxford Ovarian Cancer Predict Chemotherapy Response 01Status unknownNCT01770535
- Prognostic and Predictive Value of HE4 Biomarker in Metastatic Ovarian CancerCompletedNCT01768156Not applicable
- 18F-CP18 Imaging Studies for Cancer Treatment With BirinapantWithdrawnNCT01766622Phase 2
- Psychosexual Intervention in Patients With Stage I-III Gynecologic or Breast CancerCompletedNCT01764802Phase 2
- Stress Reduction in Improving Quality of Life in Patients With Recurrent Gynecologic or Breast CancerCompletedNCT01764789Not applicable
- Auranofin in Treating Patients With Recurrent Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube CancerCompletedNCT01747798Early Phase 1
- Cabazitaxel in Platinum Refractory Ovarian CancerTerminatedNCT01747239Phase 2
- Bevacizumab and Trabectedin +/- Carboplatin in Advanced Ovarian CancerCompletedNCT01735071Phase 2
- Endometriosis and Frequency of Endometriosis-associated Ovarian Carcinomas (EAOC)WithdrawnNCT01732432
- A Crossover Bioequivalence Study of Intravenously Administered ATI0918 and DOXIL/CAELYX in Patients With Ovarian CancerStatus unknownNCT01715168Phase 1
- Study of Clinical and Biological Prognostic Factors in Patients With Ovarian Cancer Receiving Carboplatin +Paclitaxel With BevacizumabStatus unknownNCT01706120Phase 4
- Myocet ® - Carboplatine in Ovarian Cancer in Relapse, Sensitive to the PlatinumCompletedNCT01705158Phase 1/2
- Veliparib and Topotecan for Relapsed Ovarian Cancer With Negative or Unknown BRCA StatusCompletedNCT01690598Phase 1/2
- PTX-200 and Carboplatin in Ovarian CancerTerminatedNCT01690468Phase 1/2
- Safety and Efficacy of Folatescan (Technetium TC 99M EC20) in Patients With Suspected Ovarian Carcinoma or Recurrent Endometrial CarcinomaCompletedNCT01689714Phase 2
- Safety and Biodistribution of Technetium Tc 99m EC20 in Normal Volunteers and Ovarian Cancer PatientsCompletedNCT01689636Phase 1
- A Phase 2 Study of the IDO Inhibitor Epacadostat Versus Tamoxifen for Subjects With Biochemical-recurrent-only EOC, PPC or FTC Following Complete Remission With First-line ChemotherapyTerminatedNCT01685255Phase 2
- Study on Neutropenia Induced by Adjuvant Paclitaxel/Carboplatin Chemotherapy in Patients With Epithelial Ovarian CancerStatus unknownNCT01680575
- Decitabine, Vaccine Therapy, and Pegylated Liposomal Doxorubicin Hydrochloride in Treating Patients With Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Peritoneal CancerCompletedNCT01673217Phase 1
- First-line Intraperitoneal Cisplatin and Etoposide Chemotherapy for Ovarian CancerCompletedNCT01669226Phase 2
- Olaparib for Patients With Recurrent BRCA Deficient Ovarian CancerWithdrawnNCT01661868Phase 2
- Whole-body Diffusion MRI for Staging, Response Prediction and Detecting Tumor Recurrence in Patients With Ovarian CancerCompletedNCT01657747Not applicable
- ICON8: Weekly Chemotherapy in Ovarian CancerStatus unknownNCT01654146Phase 3
- Carboplatin, Gemcitabine Hydrochloride, and Stereotactic Body Radiation Therapy in Gynecological CancerCompletedNCT01652794Phase 1
- Phase Ib Study of Olaparib Plus Weekly Carboplatin and Paclitaxel in Relapsed Ovarian CancerStatus unknownNCT01650376Phase 1/2
- A Study of MEK162 and Paclitaxel in Patients With Epithelial Ovarian, Fallopian Tube or Peritoneal CancerCompletedNCT01649336Phase 1
- Weekly Paclitaxel With or Without Pazopanib in Platinum Resistant or Refractory Ovarian CancerCompletedNCT01644825Phase 2
- Chemo-immunotherapy (Gemcitabine, Interferon-alpha 2b and p53 SLP) in Patients With Platinum-resistant Ovarian CancerCompletedNCT01639885Phase 1/2
- Feasibility of the Combination of Chemotherapy (Carbo/Caelyx or Carbo/Doxorubicin) With Tocilizumab (mAb IL-6R) and Peg-Intron in Patients With Recurrent Ovarian CancerCompletedNCT01637532Phase 1/2
- Belotecan Versus Topotecan for Recurrent Ovarian Cancer: A Randomized, Open-label, Parallel-group Phase IIb TrialCompletedNCT01630018Phase 2
- Interactive Educational Website for Women With Ovarian Cancer & CaregiversCompletedNCT01626014Early Phase 1
- BNC105P Combination Study in Partially Platinum Sensitive Ovarian Cancer PatientsWithdrawnNCT01624493Phase 1/2
- Phase I Study of the Oral PI3kinase Inhibitor BKM120 or BYL719 and the Oral PARP Inhibitor Olaparib in Patients With Recurrent Triple Negative Breast Cancer or High Grade Serous Ovarian CancerCompletedNCT01623349Phase 1
- Surgery or Chemotherapy in Recurrent Ovarian Cancer (SOC 1 Trial)?Status unknownNCT01611766Phase 3
- Low Dose Cyclophosphamide +/-- Nintedanib in Advanced Ovarian CancerCompletedNCT01610869Phase 2
- [18F]Fluciclatide-PET, Pazopanib and Paclitaxel in Ovarian CancerCompletedNCT01608009Phase 1
- Influence of Chemotherapy on Gamma-delta T Cells in Patients With Epithelial Ovarian CancerWithdrawnNCT01606358
- Vaccine Therapy and Cyclophosphamide in Treating Patients With Stage II-III Breast or Stage II-IV Ovarian, Primary Peritoneal, or Fallopian Tube CancerCompletedNCT01606241Phase 1
- Pazopanib and Weekly Topotecan in Patients Recurrent Ovarian Cancer (TOPAZ)Status unknownNCT01600573Phase 1/2
- Structural and Functional Imaging and Cognitive Functions in Ovarian CancerCompletedNCT01591772
- IPHC in Patients With Platinum-sensitive Recurrent Ovarian CancerCompletedNCT01588964Phase 2
- Vargatef in Addition to First Line Chemotherapy With Interval Debulking Surgery in Patients With Ovarian CancerCompletedNCT01583322Phase 2
- Phase I/IIa Trial of Folate Binding Protein Vaccine in Ovarian CancerCompletedNCT01580696Phase 1/2
- Mechanical Stimulation in Preventing Bone Density Loss in Patients Undergoing Donor Stem Cell TransplantWithdrawnNCT01558778Not applicable
- The Activity of TroVax® Versus Placebo in Relapsed Asymptomatic Ovarian CancerCompletedNCT01556841Phase 2
- Fallopian Tube Removal as a Method of Ovarian Cancer Prevention: A Descriptive StudyCompletedNCT01544049
- Hyperthermic Intra-peritoneal Chemotherapy (HIPEC) in Ovarian Cancer RecurrenceStatus unknownNCT01539785Not applicable
- Development for the Peritoneal Carcinomatosis Index (PCI) in Ovarian CancerCompletedNCT01538498
- A Open Label Study of the Efficacy and Safety of PD0332991 a Selective Inhibitor of the Cyclin Dependent Kinases 4 and 6 in Patients With Recurrent Ovarian Cancer Demonstrating Rb-proficiency and Low p16 ExpressionCompletedNCT01536743Phase 2
- Sirolimus and Vaccine Therapy in Treating Patients With Stage II-IV Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cavity CancerCompletedNCT01536054Phase 1
- Fenretinide/LXS Oral Powder Plus Ketoconazole in Recurrent Ovarian CancerTerminatedNCT01535157Phase 1/2
- Vaccine Therapy With or Without Sirolimus in Treating Patients With NY-ESO-1 Expressing Solid TumorsCompletedNCT01522820Phase 1
- Intraperitoneal Therapy For Ovarian Cancer With Carboplatin TrialCompletedNCT01506856Phase 2/3
- Diffusion-weighted Imaging Study in Cancer of the OvaryCompletedNCT01505829
- Propranolol Hydrochloride and Chemotherapy in Treating Patients With Ovarian, Primary Peritoneal, or Fallopian Tube CancerCompletedNCT01504126Early Phase 1
- Phase I Stereotactic Body Radiation for Metastatic or Recurrent Platinum-Resistant Ovarian CancerTerminatedNCT01494012Phase 1
- TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian CancerTerminatedNCT01493505Phase 3
- Doxorubicin + BIBF 1120 in Patients for Ovarian CancerTerminatedNCT01485874Phase 1
- EP-100 Plus Paclitaxel Versus Paclitaxel Alone in Patients With Ovarian CancerCompletedNCT01485848Phase 2
- Prolonged or Standard Infusion of Cefepime Hydrochloride in Treating Patients With Febrile NeutropeniaCompletedNCT01484015Phase 1
- A Trial Evaluating Efficacy and Safety of Oxaliplatin With 5-Fluorouracil in Patients With Recurrent Ovarian CarcinomaCompletedNCT01481701Phase 2
- Veliparib Monotherapy for Relapsed Ovarian Cancer With BRCA MutationCompletedNCT01472783Phase 1/2
- Geriatric Assessment and Nursing Telephone Intervention in Elderly Women With Ovarian CancerCompletedNCT01471483
- Hypodontia and Ovarian CancerStatus unknownNCT01470235
- A Study of DMOT4039A in Participants With Unresectable Pancreatic or Platinum-Resistant Ovarian CancerCompletedNCT01469793Phase 1
- New Biomarkers Evaluating Ovarian CancerCompletedNCT01466049
- Efficacy Study of Neoadjuvant Chemotherapy to Treat Advanced Ovarian CancerCompletedNCT01462149Phase 2